CRISPR-microfluidics nexus: Advancing biomedical applications for understanding and detection
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The integration of CRISPR technology with microfluidic-based biosensors has greatly expanded its applications in medicine and molecular biology. This combination offers enhanced sensitivity and selectivity in medical diagnostics. CRISPR-powered microfluidics enables the accurate quantification of DNA and RNA associated with diseases such as cancer, viral infections, and bacterial diseases. The precise targeting capabilities of CRISPR allow for the detection of specific genetic sequences, aiding in early diagnosis, disease monitoring, and treatment assessment. The integration of CRISPR with microfluidics improves detection sensitivity and specificity by leveraging the programmable nature of CRISPR and coupling it with signal readouts. However, challenges such as assay optimization, standardization, and device fabrication need to be addressed. Additionally, the complexity of CRISPR technology presents potential limitations in terms of off-target effects and unintended genetic modifications. Overall, the integration of CRISPR with microfluidic-based biosensors holds tremendous potential in medical diagnostics, but further research and development are required to fully exploit its benefits in clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Diversity, classification and evolution of CRISPR-Cas systems
Koonin, E. V., Makarova, K. S., & Zhang, F. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.008 · Cited by 1,423
CRISPR-Cas guides the future of genetic engineering
Knott, G. J., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aat5011 · Cited by 1,410
Antibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850
SIRT1 activation attenuates palmitate induced apoptosis in C2C12 muscle cells
Taheripak, G., Sabeti, N., Najar, N., Razavi, Z., Saharkhiz, S., & Alipourfard, I. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09250-w · Cited by 33
Self-citationZhu, Y., Li, J., Lin, X., Huang, X., & Hoffmann, M. R. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01615 · Cited by 18
Cited by
CRISPR-Driven Biosensors: A New Frontier in Rapid and Accurate Disease Detection
Razavi, Z., Soltani, M., Souri, M., & Pazoki-Toroudi, H. (2026) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2024.2400267 · Cited by 45
Self-citationKamrani, S., Naseramini, R., Khani, P., Razavi, Z. S., Afkhami, H., Atashzar, M. R., Nasri, F., Alavimanesh, S., Saeidi, F., & Ronaghi, H. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03741-x · Cited by 27
“…of alteration include methylation of DNA, changes of histones (acetylation, methylation, phosphorylation, ubiquitination, and sumoylation), and non-coding RNAs, such as RNA interacting with piwi (piRNA), microRNA (miRNA), long non-coding RNA (lncRNA), and small interfering RNA (siRNA) [132, 133].”
Self-citationNew perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells
Farokhi, S., Razavi, Z.-S., Mavaei, M., Shadab, A., Afkhami, H., & Sardarabadi, H. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-06113-8 · Cited by 27
Self-citationMicrofluidic systems for modeling digestive cancer: a review of recent progress
Razavi, Z., Soltani, M., Pazoki-Toroudi, H., & Dabagh, M. (2024) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ad6f15 · Cited by 24
Self-citation
Metadata
- Authors
- Razavi, Z., Soltani, M., Pazoki-Toroudi, H., & Chen, P.
- Venue
- Sensors and Actuators A: Physical
- Publisher
- Elsevier BV
- Published
- 2024-10
- Volume
- 376
- Pages
- 115625
- ISSN
- 0924-4247 (ISSN-L)
- OpenAlex
- W4399944072
- Cited by
- 42
- References
- 7
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CRISPR-microfluidics nexus: Advancing biomedical applications for understanding and detection. https://app.cochat.ai/papers/10.1016/j.sna.2024.115625
- The paper
- Razavi, Z., Soltani, M., Pazoki-Toroudi, H., & Chen, P. (2024). CRISPR-microfluidics nexus: Advancing biomedical applications for understanding and detection. Sensors and Actuators A: Physical. https://doi.org/10.1016/j.sna.2024.115625
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.